EGFR and colorectal carcinoma: Furthermore, Du et al. found that the expression of EGFR is closely correlated with progression-free survival (PFS) in post-operative patients with colorectal carcinoma, as patients with high EGFR expression were at a higher risk of tumor progression when comparing with their counterparts [55].